BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30776040)

  • 1. Amorphous nanoparticles by self-assembly: processing for controlled release of hydrophobic molecules.
    Feng J; Zhang Y; McManus SA; Qian R; Ristroph KD; Ramachandruni H; Gong K; White CE; Rawal A; Prud'homme RK
    Soft Matter; 2019 Mar; 15(11):2400-2410. PubMed ID: 30776040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.
    Feng J; Markwalter CE; Tian C; Armstrong M; Prud'homme RK
    J Transl Med; 2019 Jun; 17(1):200. PubMed ID: 31200738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray drying OZ439 nanoparticles to form stable, water-dispersible powders for oral malaria therapy.
    Ristroph KD; Feng J; McManus SA; Zhang Y; Gong K; Ramachandruni H; White CE; Prud'homme RK
    J Transl Med; 2019 Mar; 17(1):97. PubMed ID: 30902103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti-
    Feng J; Zhang Y; McManus SA; Ristroph KD; Lu HD; Gong K; White CE; Prud'homme RK
    ACS Appl Nano Mater; 2018 May; 1(5):2184-2194. PubMed ID: 29911689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and Scale-Up of Fast-Dissolving Lumefantrine Nanoparticles for Oral Malaria Therapy.
    Armstrong M; Wang L; Ristroph K; Tian C; Yang J; Ma L; Panmai S; Zhang D; Nagapudi K; Prud'homme RK
    J Pharm Sci; 2023 Aug; 112(8):2267-2275. PubMed ID: 37030438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an
    Caggiano NJ; Wilson BK; Priestley RD; Prud'homme RK
    Mol Pharm; 2022 May; 19(5):1515-1525. PubMed ID: 35412842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
    Xiong X; Xu K; Li S; Tang P; Xiao Y; Li H
    Drug Dev Ind Pharm; 2017 Feb; 43(2):283-292. PubMed ID: 27648489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous-based controlled-release gliclazide matrix system.
    Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Fassihi R
    AAPS PharmSciTech; 2017 Jul; 18(5):1699-1709. PubMed ID: 27714702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersaturated controlled release matrix using amorphous dispersions of glipizide.
    Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Ilies MA; Fassihi R
    Int J Pharm; 2016 Sep; 511(2):957-68. PubMed ID: 27492020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Millisecond Self-Assembly of Stable Nanodispersed Drug Formulations.
    Pansare VJ; Rawal A; Goodwin A; Beyerinck R; Prud'homme RK; Friesen DT; Grass M; Muske-Dukes A; Vodak DT
    Mol Pharm; 2018 Feb; 15(2):495-507. PubMed ID: 29244515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions.
    Correa-Soto C; Trasi NS; Schmitt PD; Su Y; Liu Z; Miller E; Variankaval N; Marsac PJ; Simpson GJ; Taylor LS
    J Pharm Biomed Anal; 2017 Nov; 146():86-95. PubMed ID: 28866472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.
    Zhang Y; Feng J; McManus SA; Lu HD; Ristroph KD; Cho EJ; Dobrijevic EL; Chan HK; Prud'homme RK
    Mol Pharm; 2017 Oct; 14(10):3480-3488. PubMed ID: 28929769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.
    Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT
    J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.
    Friesen DT; Shanker R; Crew M; Smithey DT; Curatolo WJ; Nightingale JA
    Mol Pharm; 2008; 5(6):1003-19. PubMed ID: 19040386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.